Sex difference in up-regulation of nicotine acetylcholine receptors in rat brain

Life Sciences

Volumn 61, Issue 12, 1997, Pages

  Koylu, Ersin ^a   Demirgören, Serdar ^a   London, Edythe D ^b   Pöǧün, Şakire ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Cystine; Nicotine; Nicotine acetylcholine receptor; Sex differences; Up regulation; Withdrawal

Indexed keywords

CYTISINE; NICOTINE; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN REGION; CONTROLLED STUDY; DRUG TOXICITY; DRUG WITHDRAWAL; FEMALE; LONG TERM EXPOSURE; MALE; NONHUMAN; RAT; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SEX DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

ALKALOIDS; ANIMALS; AZOCINES; BRAIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; KINETICS; MALE; NICOTINE; QUINOLIZINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SEX CHARACTERISTICS; TIME FACTORS; UP-REGULATION;

ANIMALIA;

EID: 0342618409     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00665-6     Document Type: Article

References (19)

1. M.C. FIORE, The Med. Clin. of North America 76 289-303 (1992).
2. M.E.M BENWELL, D.J.K. BALFOUR and J.M. ANDERSON, J. Neurochem. 50 1243-1247 (1988).
3. V HAROUTUNIAN, E. BARNES and K.L. DAVIS, Psychopharmacol. 87 266-271 (1985).
4. D.M. GILLIAM and K. SCHLESINGER, Psychopharmacol. 86 291-295 (1985).
5. A. OLIVERIO, J. Pharmacol. Exp. Ther., 154 350-356 (1966).
6. Ö. YILMAZ, L. KANIT, B.E. OKUR and Ş. PÖǦÜN, Behav. Pharmacol. (In press) (1997)
7. L.A. PABREZA, , S. DHAWAN and K.J. KELLAR, Mol. Pharmacol. 39 9-12 (1991).
8. J.E. FLESHER, U. SCHEFFEL, E.D. LONDON, AND J.J. FROST, Life Sci, 54 1883-1890 (1994).
9. C. KSIR, R. HAKAN, D.P. HALL and K.J., KELLAR, Neuropharmacol. 24 527-531 (1985).
10. M.J. MARKS, E. ROMM and A.C. COLLINS, J. Pharmacol. Exp. Ther. 235 619-628 (1985).
11. E.M. SANDERSON, A.L. DRASDO, K. McCREA and S. WONNACOT, Brain Res 617 349-352 (1993).
12. M.E.M. BENWELL and D.J.K. BALFOUR, J. Pharm. Pharmacol. 37 405-409 (1985).
13. A.C. COLLINS, E. ROMM and J.M. WEHNER, Psychopharmacol 96 7-14 (1988).
14. A.C. COLLINS, E. ROMM and J.M. WEHNER, Brain Res. Bull. 25 373-379 (1990).
15. Y. TIZABE, E.J. POPKE, M.A. RAHMAN, S.M. NESPOR and N.E. GRUNBERG, Pharmacol. Biochem. Behav. (In press)
16. C.M. FLORES, S.W. ROGERS, L.A. PABREZA, B.B. WOLFE and K.J. KELLAR, Mol. Pharmacol. 41 31-37 (1992).
17. L. KE and R.J. LUKAS, J Neurochem. 67 1100-1112 (1996).
18. F.J. BARRANTES, FASEB J. 7 1460-1467 (1993).
19. S. VALERA, M. BALLIVET, and D. BERTRAND, Proc. Natl. Acad. Sci. USA 89 9945-9953 (1992).